Navigation Links
Cholera strain evolves new mechanism for causing disease
Date:12/9/2010

New clinical strains of cholera appear to have evolved a distinctly different mechanism to cause the same disease according to research published in the current issue of the online journal mBio.

Vibrio cholerae is the causative agent for the diarrheal disease cholera. While there are more than 200 different serogroups only the O1 and the O139 strains have been known to cause epidemic and pandemic outbreaks of disease, using a toxin-coregulated pilus (TCP) and cholera toxin (CT), which other strains lack.

"While non-O1, non-O139 strains have caused sporadic disease globally, the virulence mechanisms are not fully understood, since most of these strains lack TCP and CT," say the researchers from Harvard Medical School and the International Center for Diarrhoeal Research in Dhaka, Bangladesh.

The researchers studied a newly identified non-O1, non-O139 strain of the bacteria called AM-19226. Using comparative genomics, they investigated how this new strain causes diarrhea.

Many pathogenic bacteria require something called a type III secretion system (T3SS) in order to cause disease. In previous studies, the researchers discovered a T3SS and identified a protein (vopF) that they believe could be involved in causing disease.

In the current study they identified an additional protein (vopE) and using mouse models show that AM-19226 requires T3SS to cause diarrhea and that both vopE and vopF contribute to the disease.

"With the discovery of the T3SS in V. cholerae and its role in the virulence of non-O1 and non-O139 strains, it is astonishing to observe how this bacterium has evolved two independent pathogenic mechanisms to cause similar disease," say the researchers.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. Polarized light guides cholera-carrying midges that contaminate water supplies
2. UCF professors vaccine could be lethal weapon against malaria, cholera
3. Dartmouth researchers describe how the cholera bacteria becomes infectious
4. Sari cloth a simple sustainable protector from cholera
5. Rensselaer professor uncovers mysterious workings of cholera bacteria
6. Researchers recreate SARS virus, open door for potential defenses against future strains
7. Strained quantum dots show new optical properties
8. Knee injuries may start with strain on the brain, not the muscles
9. Novel bacterial strains clear algal toxins from drinking water
10. Genomes of 2 popular research strains of E. coli sequenced
11. New, virulent strain of MRSA poses renewed antibiotic resistance concerns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/21/2016)... -- Unique technology combines v ...   Xura, Inc. (NASDAQ: ... communications services, today announced it is working alongside SpeechPro ... particularly those in the Financial Services Sector, the ability ... a mobile app, alongside, and in combination with, traditional ...
(Date:3/15/2016)... 15, 2016 Yissum Research Development Company ... company of the Hebrew University, announced today the formation ... technology of various human biological indicators. Neteera Technologies has ... from private investors. ... detection of electromagnetic emissions from sweat ducts, enables reliable ...
(Date:3/11/2016)... , March 11, 2016 ... new market research report "Image Recognition Market by Technology ... (Marketing and Advertising), by Deployment Type (On-Premises and Cloud), ... To 2022", published by MarketsandMarkets, the global market is ... to USD 29.98 Billion by 2020, at a CAGR ...
Breaking Biology News(10 mins):
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... manufacturing company, today announced several positive developments that position the Company for the ... result of the transaction, Craig F. Kinghorn has been appointed Chairman of the ...
(Date:5/25/2016)... ... 2016 , ... Founder of the Fitzmaurice Hand Institute in ... of the hand by the National Board of Physicians and Surgeons, as of ... in his pursuit of providing the most comprehensive, effective treatment for his patients, ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. ... the company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar ... FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is ...
(Date:5/23/2016)... ... ... need for blood donations in South Texas and across the nation is growing. , But ... blood donations are on the decline. In fact, donations across the country are at their ... Texas in the last four years alone. , There is no substitute for blood. , ...
Breaking Biology Technology: